Published in Menopause on January 11, 2010
Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med (2012) 5.81
Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort. Osteoporos Int (2012) 2.02
Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women. Int J Gen Med (2013) 1.49
Baseline age and time to major fracture in younger postmenopausal women. Menopause (2015) 1.49
Smartphone Medical Applications for Women's Health: What Is the Evidence-Base and Feedback? Int J Telemed Appl (2013) 1.26
Lumbar spine bone mineral density in US adults: demographic patterns and relationship with femur neck skeletal status. Osteoporos Int (2011) 1.20
Individualizing osteoporosis therapy. Osteoporos Int (2012) 1.15
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study. Osteoporos Int (2011) 1.13
Overuse of short-interval bone densitometry: assessing rates of low-value care. Osteoporos Int (2014) 1.04
Incidence and Predictors of Repeat Bone Mineral Densitometry: A Longitudinal Cohort Study. J Gen Intern Med (2017) 1.02
Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2010) 0.93
Low Bone Mineral Density in Middle-Aged Breast Cancer Survivors: Prevalence and Associated Factors. Breast Care (Basel) (2012) 0.93
A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos (2016) 0.92
Exercise beyond menopause: Dos and Don'ts. J Midlife Health (2011) 0.92
Quality of fracture risk assessment in post-fracture care in Ontario, Canada. Osteoporos Int (2012) 0.88
MENOPOST--calcium and vitamin D supplementation in postmenopausal osteoporosis treatment: a descriptive cohort study. Osteoporos Int (2012) 0.86
Skeletal response to resistance and impact training in prostate cancer survivors. Med Sci Sports Exerc (2014) 0.86
Impact of a change in physician reimbursement on bone mineral density testing in Ontario, Canada: a population-based study. CMAJ Open (2014) 0.86
Osteoporosis medication adherence: physician perceptions vs. patients' utilization. Bone (2013) 0.85
Clinical efficacy and treatment persistence of monthly minodronate for osteoporotic patients unsatisfied with, and shifted from, daily or weekly bisphosphonates: the BP-MUSASHI study. Osteoporos Int (2014) 0.85
7 Tesla MRI of bone microarchitecture discriminates between women without and with fragility fractures who do not differ by bone mineral density. J Bone Miner Metab (2014) 0.84
Epidemiology and management of osteoporosis in the People's Republic of China: current perspectives. Clin Interv Aging (2015) 0.84
Oophorectomy: the debate between ovarian conservation and elective oophorectomy. Menopause (2013) 0.84
Bone and the perimenopause. Obstet Gynecol Clin North Am (2011) 0.84
Osteoporosis onset differences between rural and metropolitan populations: correlation to fracture type, severity, and treatment efficacy. J Bone Miner Metab (2011) 0.82
First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates. J Midlife Health (2014) 0.82
Low appendicular muscle mass is correlated with femoral neck bone mineral density loss in postmenopausal women. BMC Musculoskelet Disord (2011) 0.82
Effectiveness and characteristics of multifaceted osteoporosis group education--a systematic review. Osteoporos Int (2013) 0.82
Systematic review of the association between climate and hip fractures. Int J Biometeorol (2014) 0.81
Fracture risk in older, long-term survivors of early-stage breast cancer. J Am Geriatr Soc (2013) 0.81
Determination of an applicable FRAX model in Korean women. J Korean Med Sci (2010) 0.81
Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis. Ther Adv Musculoskelet Dis (2012) 0.80
The evolution of selective estrogen receptor modulators in osteoporosis therapy. Climacteric (2012) 0.80
Fracture predictive ability of physical performance tests and history of falls in elderly women: a 10-year prospective study. Osteoporos Int (2015) 0.79
Response to an adequate dietary intake of vitamin D3 modulates the effect of estrogen therapy on bone density. J Womens Health (Larchmt) (2012) 0.79
Pulsed electromagnetic field stimulates osteoprotegerin and reduces RANKL expression in ovariectomized rats. Rheumatol Int (2012) 0.79
Influence of weight training on skeletal health of breast cancer survivors with or at risk for breast cancer-related lymphedema. J Cancer Surviv (2014) 0.79
Organic nitrate maintains bone marrow blood perfusion in ovariectomized female rats: a dynamic, contrast-enhanced magnetic resonance imaging (MRI) study. Pharmaceutics (2012) 0.79
Vitamin/trace mineral supplements for the elderly. Adv Nutr (2012) 0.78
Agreement between physicians' and nurses' clinical decisions for the management of the fracture liaison service (4iFLS): the Lucky Bone™ program. Osteoporos Int (2015) 0.78
Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis. J Endocrinol Invest (2016) 0.77
Menopause in multiple sclerosis: therapeutic considerations. J Neurol (2013) 0.77
Gastrointestinal events and association with initiation of treatment for osteoporosis. Clinicoecon Outcomes Res (2015) 0.77
Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy. Int J Womens Health (2012) 0.77
Low BMI and low TSH value as risk factors related to lower bone mineral density in postmenospausal women under levothyroxine therapy for differentiated thyroid carcinoma. Thyroid Res (2015) 0.77
Treatment of osteoporosis: current state of the art. Wien Med Wochenschr (2014) 0.77
Long-term persistence and switching patterns among women using osteoporosis therapies: 24- and 36-month results from POSSIBLE US™. Osteoporos Int (2014) 0.77
BMD screening in older women: initial measurement and testing interval. J Bone Miner Res (2012) 0.76
Dioxin-like compounds are not associated with bone strength measured by ultrasonography in Inuit women from Nunavik (Canada): results of a cross-sectional study. Int J Circumpolar Health (2013) 0.76
Epidemiology of the symptoms of menopause - an intercontinental review. Prz Menopauzalny (2014) 0.76
Associations between body composition and lifestyle factors with bone mineral density according to time since menopause in women from Southern Brazil: a cross-sectional study. BMC Endocr Disord (2015) 0.76
A clinician performance initiative to improve quality of care for patients with osteoporosis. J Womens Health (Larchmt) (2013) 0.76
The effects of bazedoxifene in the ovariectomized aged cynomolgus monkey. J Bone Miner Metab (2014) 0.76
The tissue selective estrogen complex: a promising new menopausal therapy. Pharmaceuticals (Basel) (2012) 0.76
Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates. Clin Interv Aging (2016) 0.75
Bone: Is screening for secondary causes of osteoporosis worthwhile? Nat Rev Endocrinol (2010) 0.75
Assessment of the presence and quality of osteoporosis prevention education among at-risk internal medicine patients. Consult Pharm (2014) 0.75
Risedronate's Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis. Clin Med Insights Arthritis Musculoskelet Disord (2012) 0.75
Psychometric properties of the osteoporosis assessment questionnaire (OPAQ) 2.0: results from the multiple outcomes of raloxifene evaluation (MORE) study. BMC Musculoskelet Disord (2014) 0.75
Update in new medications for primary care. J Gen Intern Med (2010) 0.75
The analysis of knee joint loading during drop landing from different heights and under different instruction sets in healthy males. Sports Med Open (2017) 0.75
Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan. Osteoporos Int (2014) 0.75
Evaluation of Patients' Response Toward Osteoporosis Letter Intervention Versus Phone Call Plus Letter Intervention. Geriatr Orthop Surg Rehabil (2015) 0.75
Preventing fractures in postmenopausal women: how to assess risk. CMAJ (2011) 0.75
Moving toward a prevention strategy for osteoporosis by giving a voice to a silent disease. Womens Midlife Health (2016) 0.75
Dietary Polyphenols, Berries, and Age-Related Bone Loss: A Review Based on Human, Animal, and Cell Studies. Antioxidants (Basel) (2014) 0.75
Soy consumption during menopause. Facts Views Vis Obgyn (2012) 0.75
Cardiopulmonary effects of traditional Thai dance on menopausal women: a randomized controlled trial. J Phys Ther Sci (2015) 0.75
Dioxin-like compounds and bone quality in Cree women of Eastern James Bay (Canada): a cross-sectional study. Environ Health (2013) 0.75
Targeted assessment of fracture risk in women at midlife. Osteoporos Int (2015) 0.75
Bridging analysis of the efficacy and safety of bazedoxifene in Japanese and global populations of postmenopausal women with osteoporosis. J Bone Miner Metab (2014) 0.75
Quantitative analysis of efficacy and associated factors of calcium intake on bone mineral density in postmenopausal women. Osteoporos Int (2017) 0.75
Low plasma PDGF-BB levels are associated with estradiol in postmenopausal osteoporosis. J Int Med Res (2017) 0.75